<DOC>
	<DOCNO>NCT01564771</DOCNO>
	<brief_summary>Serotype distribution estimation antimicrobial resistance S. pneumoniae isolates anticipate PCV7 PCV13 coverage difficult Greece , invasive isolates collect year limit depict certain proportion patient easy access tertiary care underlie medical reason necessitate inpatient care . It also probable real burden pneumococcal disease well estimate especially among adult . New addition laboratory set pneumococcal urine antigen assay ( Binax NOW® ) Urinary Antigen Diagnostic Assay ( Luminex ) detection 13 serotype specific polysaccharide human urine develop Pfizer might helpful identify pneumococcal infection compare previous year . This NIS base unmet scientific need describe serotype distribution resistance profile isolate X-Ray confirm CAP present circumstance .</brief_summary>
	<brief_title>Serotype Distribution Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia Adult Population Greece , Over 1 Year .</brief_title>
	<detailed_description>For surveillance period last 12 month adult present select clinic symptom sign suggestive pneumonia ( candidate case ) ask participate study</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<criteria>Patients agree participate study agree sign ICD . Patients ≥18 year age ( adult ) Patients present refer participate healthcare facility suspect pneumonia base physician 's assessment ( include limit specific sign symptom describe Section 9.3 protocol ) Patients must posteroanterior anteroposterior chest Xray show infiltrate ( previous film available ) new infiltrate ( recent film available ) Patients test positive Binax NOW® assay ( require post Protocol Amendment 2 ) Patients sign ICD . Any patient develop sign symptom pneumonia hospitalize ≥48 hour Any patient transfer study healthcare facility already hospitalize ≥48 hour another healthcare facility Patients chest Xray perform Patients Binax NOW® assay perform Patients negative result Binax NOW® assay ( require post Protocol Amendment 2 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Pneumococcal serotypes</keyword>
	<keyword>Community Acquired Pneumonia ( CAP )</keyword>
</DOC>